A FOUR -WEEK COMPARISON OF BI-MATOPROST 0.03% AND BIMATOPROST 0.015% IN PATIENTS WITH ELEVATED INTRAOCULAR PRESSURE J.A. Ferreira, G.A.S.

Purpose: Intraocular Pressure (IOP) control is the main goal in glaucoma treatment However, despite satisfactory control, the occurrence of side effects reduces compliance. This study was designed to test if an ophthalmic preparation of 50% diluted bi-matoprost (bimatoprost 0.015%) achieves good IOP